MAX Chat
Company Analysis LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
1. Summary
Advantages
- Dividends (3.03%) are higher than the sector average (2.97%).
- The company's current efficiency (ROE=12.52%) is higher than the sector average (ROE=-5.11%)
Disadvantages
- Price (21.48 HK$) is higher than fair price (11.61 HK$)
- The stock's return over the last year (22.74%) is lower than the sector average (32.31%).
- Current debt level 0.146% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -3.3% | 2% | 2.7% |
| 90 days | 3.3% | 49.4% | 13.5% |
| 1 year | 22.7% | 32.3% | 52.4% |
2291 vs Sector: LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has significantly underperformed the "Healthcare" sector by -9.57% over the past year.
2291 vs Market: LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has significantly underperformed the market by -29.63% over the past year.
Stable price: 2291 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 2291 with weekly volatility of 0.4374% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (21.48 HK$) is higher than the fair price (11.61 HK$).
Price is higher than fair: The current price (21.48 HK$) is 45.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (23.11) is higher than that of the sector as a whole (-27.77).
P/E vs Market: The company's P/E (23.11) is lower than that of the market as a whole (23.3).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.84) is lower than that of the sector as a whole (3.06).
P/BV vs Market: The company's P/BV (2.84) is higher than that of the market as a whole (2.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (12.03) is lower than that of the sector as a whole (54.94).
P/S vs Market: The company's P/S indicator (12.03) is lower than that of the market as a whole (19.57).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (478.52) is higher than that of the sector as a whole (28.92).
EV/Ebitda vs Market: The company's EV/Ebitda (478.52) is higher than that of the market as a whole (37.51).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 57.33% over the last 5 years.
Earnings Slowdown: The last year's return (-0.412%) is below the 5-year average return (57.33%).
Profitability vs Sector: The return for the last year (-0.412%) is lower than the return for the sector (2.95%).
5.4. ROE
ROE vs Sector: The company's ROE (12.52%) is higher than that of the sector as a whole (-5.11%).
ROE vs Market: The company's ROE (12.52%) is higher than that of the market as a whole (-4.45%).
5.5. ROA
ROA vs Sector: The company's ROA (12.07%) is higher than that of the sector as a whole (0.2788%).
ROA vs Market: The company's ROA (12.07%) is higher than that of the market as a whole (2.7%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (14.67%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.03% is higher than the average for the sector '2.97%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.03% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 3.03% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (79.32%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
